Resultados de búsqueda - Langkilde, Anna Maria

Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Pl... por Strojek, Krzysztof, Yoon, Kun-Ho, Hruba, Veronika, Sugg, Jennifer, Langkilde, Anna Maria, Parikh, Shamik

Enlace del recurso Enlace del recurso Enlace del recurso

SAT-LB025 Analysis of Benefit/Risk in the Subgroup of Patients with BMI of >=27 Kg/m(2) in the Dapagliflozin DEPICT-1 and -2 Trials in Type 1 Diabetes por Mathieu, Chantal, Dandona, Paresh, Phillip, Moshe, Xu, John, Thorén, Fredrik, Scheerer, Markus, Langkilde, Anna-Maria

Enlace del recurso Enlace del recurso

Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study por Kaku, Kohei, Maegawa, Hiroshi, Tanizawa, Yukio, Kiyosue, Arihiro, Ide, Yumiko, Tokudome, Takuto, Hoshino, Yuji, Yang, Jisin, Langkilde, Anna Maria

Enlace del recurso Enlace del recurso Enlace del recurso

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis por Block, Geoffrey A., Rosenbaum, David P., Leonsson-Zachrisson, Maria, Åstrand, Magnus, Johansson, Susanne, Knutsson, Mikael, Langkilde, Anna Maria, Chertow, Glenn M.

Enlace del recurso Enlace del recurso Enlace del recurso

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study por Fioretto, Paola, Del Prato, Stefano, Buse, John B., Goldenberg, Ronald, Giorgino, Francesco, Reyner, Daniel, Langkilde, Anna Maria, Sjöström, C. David, Sartipy, Peter

Enlace del recurso Enlace del recurso Enlace del recurso

The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart Failure por BJORNSTAD, PETTER, GREASLEY, PETER J., WHEELER, DAVID C., CHERTOW, GLENN M., LANGKILDE, ANNA MARIA, HEERSPINK, HIDDO J.L., VAN RAALTE, DANIËL H.

Enlace del recurso Enlace del recurso Enlace del recurso

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical... por Araki, Eiichi, Watada, Hirotaka, Uchigata, Yasuko, Tomonaga, Osamu, Fujii, Hitomi, Ohashi, Hiroshi, Okabe, Tadashi, Asano, Michiko, Thoren, Fredrik, Kim, Hyosung, Yajima, Toshitaka, Langkilde, Anna Maria

Enlace del recurso Enlace del recurso Enlace del recurso

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial por Heerspink, Hiddo J L, Stefansson, Bergur V, Chertow, Glenn M, Correa-Rotter, Ricardo, Greene, Tom, Hou, Fan-Fan, Lindberg, Magnus, McMurray, John, Rossing, Peter, Toto, Roberto, Langkilde, Anna Maria, Wheeler, David C

Enlace del recurso Enlace del recurso Enlace del recurso

Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the DARE‐19 study... por Kosiborod, Mikhail, Berwanger, Otavio, Koch, Gary G., Martinez, Felipe, Mukhtar, Omar, Verma, Subodh, Chopra, Vijay, Javaheri, Ali, Ambery, Philip, Gasparyan, Samvel B., Buenconsejo, Joan, Sjöström, C. David, Langkilde, Anna Maria, Oscarsson, Jan, Esterline, Russell

Enlace del recurso Enlace del recurso Enlace del recurso

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy? por Yeoh, Su E., Dewan, Pooja, Jhund, Pardeep S., Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Solomon, Scott D., Bengtsson, Olof, Sjöstrand, Mikaela, Langkilde, Anna Maria, McMurray, John JV

Enlace del recurso Enlace del recurso Enlace del recurso

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy por Docherty, Kieran F., Jhund, Pardeep S., Bengtsson, Olof, DeMets, David L., Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Langkilde, Anna Maria, Martinez, Felipe A., Sabatine, Marc S., Sjöstrand, Mikaela, Solomon, Scott D., McMurray, John J.V.

Enlace del recurso Enlace del recurso Enlace del recurso

The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists por Provenzano, Michele, Jongs, Niels, Vart, Priya, Stefánsson, Bergur V., Chertow, Glenn M., Langkilde, Anna Maria, McMurray, John J.V., Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C. David, Toto, Robert D., Wheeler, David C., Heerspink, Hiddo J.L.

Enlace del recurso Enlace del recurso Enlace del recurso

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial por Heerspink, Hiddo J L, Sjöström, C David, Jongs, Niels, Chertow, Glenn M, Kosiborod, Mikhail, Hou, Fan Fan, McMurray, John J V, Rossing, Peter, Correa-Rotter, Ricardo, Kurlyandskaya, Raisa, Stefansson, Bergur V, Toto, Robert D, Langkilde, Anna Maria, Wheeler, David C

Enlace del recurso Enlace del recurso Enlace del recurso

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial por Persson, Frederik, Rossing, Peter, Vart, Priya, Chertow, Glenn M., Hou, Fan Fan, Jongs, Niels, McMurray, John J.V., Correa-Rotter, Ricardo, Bajaj, Harpreet S., Stefansson, Bergur V., Toto, Robert D., Langkilde, Anna Maria, Wheeler, David C., Heerspink, Hiddo J.L.

Enlace del recurso Enlace del recurso Enlace del recurso

Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF por Curtain, James P, Docherty, Kieran F, Jhund, Pardeep S, Petrie, Mark C, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Martinez, Felipe A, Ponikowski, Piotr, Sabatine, Marc S, Bengtsson, Olof, Langkilde, Anna Maria, Sjöstrand, Mikaela, Solomon, Scott D, McMurray, John J V

Enlace del recurso Enlace del recurso Enlace del recurso

Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Random... por Docherty, Kieran F., Jhund, Pardeep S., Claggett, Brian, Ferreira, João Pedro, Bengtsson, Olof, Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Langkilde, Anna Maria, Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Sjöstrand, Mikaela, Solomon, Scott D., McMurray, John J. V.

Enlace del recurso Enlace del recurso Enlace del recurso

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus por Berg, David D., Wiviott, Stephen D., Scirica, Benjamin M., Gurmu, Yared, Mosenzon, Ofri, Murphy, Sabina A., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John, Johanson, Per, Johansson, Peter A., Langkilde, Anna Maria, Raz, Itamar, Braunwald, Eugene, Sabatine, Marc S.

Enlace del recurso Enlace del recurso Enlace del recurso

Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction por Berg, David D., Jhund, Pardeep S., Docherty, Kieran F., Murphy, Sabina A., Verma, Subodh, Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Langkilde, Anna Maria, Martinez, Felipe A., Bengtsson, Olof, Ponikowski, Piotr, Sjöstrand, Mikaela, Solomon, Scott D., McMurray, John J. V., Sabatine, Marc S.

Enlace del recurso Enlace del recurso Enlace del recurso

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease por Chertow, Glenn M., Vart, Priya, Jongs, Niels, Toto, Robert D., Gorriz, Jose Luis, Hou, Fan Fan, McMurray, John J.V., Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C. David, Stefánsson, Bergur V., Langkilde, Anna Maria, Wheeler, David C., Heerspink, Hiddo J.L.

Enlace del recurso Enlace del recurso Enlace del recurso

Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis... por Zelniker, Thomas A., Raz, Itamar, Mosenzon, Ofri, Dwyer, Jamie P., Heerspink, Hiddo H. J. L., Cahn, Avivit, Goodrich, Erica L., Im, Kyungah, Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P. H., Gause-Nilsson, Ingrid, Langkilde, Anna Maria, Sabatine, Marc S., Wiviott, Stephen D.

Enlace del recurso Enlace del recurso Enlace del recurso